Cargando…

JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells

OBJECTIVE: Successful treatment of solid cancers mandates targeting cancer stem cells (CSC) without impact on the physiology of normal tissue resident stem cells. C-Jun N-terminal kinase (JNK) signaling has been shown to be of importance in cancer. We test whether JNK inhibition would sensitize panc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Recio-Boiles, Alejandro, Ilmer, Matthias, Rhea, P. Robyn, Kettlun, Claudia, Heinemann, Mitja L., Ruetering, Jennifer, Vykoukal, Jody, Alt, Eckhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891091/ https://www.ncbi.nlm.nih.gov/pubmed/26840266 http://dx.doi.org/10.18632/oncotarget.7066

Ejemplares similares

Improved Method for Isolation of Neonatal Rat Cardiomyocytes with Increased Yield of C-Kit+ Cardiac Progenitor Cells
por: Rutering, Jennifer, et al.
Publicado: (2015)

Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics
por: Ilmer, Matthias, et al.
Publicado: (2016)

Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells
por: Ilmer, Matthias, et al.
Publicado: (2016)

Unmodified autologous stem cells at point of care for chronic myocardial infarction
por: Haenel, Alexander, et al.
Publicado: (2019)

TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population
por: Loebinger, M R, et al.
Publicado: (2010)

Stem cells are resistant to TRAIL receptor-mediated apoptosis
por: Szegezdi, Eva, et al.
Publicado: (2009)

JNK Signaling in Stem Cell Self-Renewal and Differentiation
por: Semba, Takashi, et al.
Publicado: (2020)

Behind the Adaptive and Resistance Mechanisms of Cancer Stem Cells to TRAIL
por: Quiroz-Reyes, Adriana G., et al.
Publicado: (2021)

Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ
por: Reagan, Michaela R., et al.
Publicado: (2012)

Targeting JNK for therapeutic depletion of stem-like glioblastoma cells
por: Matsuda, Ken-ichiro, et al.
Publicado: (2012)

The Emerging Roles of JNK Signaling in Drosophila Stem Cell Homeostasis
por: Herrera, Salvador C., et al.
Publicado: (2021)

Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy
por: Wei, Zheng Z, et al.
Publicado: (2017)

Conversion of Unmodified Stem Cells to Pacemaker Cells by Overexpression of Key Developmental Genes
por: Karimi, Tahereh, et al.
Publicado: (2023)

Evaluating the Effect of Therapeutic Stem Cells on TRAIL Resistant and Sensitive Medulloblastomas
por: Nesterenko, Irina, et al.
Publicado: (2012)

Safety and Efficacy of Autologous Stem Cell Treatment for Facetogenic Chronic Back Pain
por: Rothoerl, Ralf, et al.
Publicado: (2023)

Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction
por: Carvalho, Juliana L, et al.
Publicado: (2013)

Efficient derivation of human trophoblast stem cells from primed pluripotent stem cells
por: Wei, Yanxing, et al.
Publicado: (2021)

Induction of human trophoblast stem-like cells from primed pluripotent stem cells
por: Jang, Yu Jin, et al.
Publicado: (2022)

Derivation of functional trophoblast stem cells from primed human pluripotent stem cells
por: Soncin, Francesca, et al.
Publicado: (2022)

Resident stem cells in the heart
por: Gong, Hui, et al.
Publicado: (2021)

Targeting JNK pathway promotes human hematopoietic stem cell expansion
por: Xiao, Xiong, et al.
Publicado: (2019)

Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines
por: Mahalingam, D, et al.
Publicado: (2009)

Protocol to derive human trophoblast stem cells directly from primed pluripotent stem cells
por: Wei, Yanxing, et al.
Publicado: (2022)

Human Embryonic Stem Cells Acquire Responsiveness to TRAIL upon Exposure to Cisplatin
por: Pešková, Lucie, et al.
Publicado: (2019)

Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
por: Shaik Fakiruddin, Kamal, et al.
Publicado: (2018)

Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
por: Kazimirsky, Gila, et al.
Publicado: (2016)

Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
por: Renz, Bernhard W., et al.
Publicado: (2017)

Resident Stem Cells and Renal Carcinoma
por: Bussolati, Benedetta, et al.
Publicado: (2011)

Chondrogenic priming of human fetal synovium-derived stem cells in an adult stem cell matrix microenvironment
por: Li, Jingting, et al.
Publicado: (2015)

The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo
por: Okada, Masashi, et al.
Publicado: (2016)

Perspective: Why and How Ubiquitously Distributed, Vascular-Associated, Pluripotent Stem Cells in the Adult Body (vaPS Cells) Are the Next Generation of Medicine
por: Alt, Eckhard U., et al.
Publicado: (2021)

Shikonin sensitizes A549 cells to TRAIL-induced apoptosis through the JNK, STAT3 and AKT pathways
por: Guo, Zhi Lan, et al.
Publicado: (2018)

Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus
por: Yang, Yu, et al.
Publicado: (2015)

Adipose-derived mesenchymal stem cell-facilitated TRAIL expression in melanoma treatment in vitro
por: JING, HAI XIA, et al.
Publicado: (2016)

Epigenetic differences between naïve and primed pluripotent stem cells
por: Takahashi, Saori, et al.
Publicado: (2017)

Helios represses megakaryocyte priming in hematopoietic stem and progenitor cells
por: Cova, Giovanni, et al.
Publicado: (2021)

Suppressive effect mediated by human adipose-derived stem cells on T cells involves the activation of JNK
por: Wang, Yinmin, et al.
Publicado: (2019)

Dexamethasone priming enhances stemness and immunomodulatory property of tissue-specific human mesenchymal stem cells
por: Rawat, Sonali, et al.
Publicado: (2021)

Letter to the Editor on “Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL”
por: Liu, Mingli
Publicado: (2017)

Priming Mesenchymal Stem Cells with Endothelial Growth Medium Boosts Stem Cell Therapy for Systemic Arterial Hypertension
por: de Oliveira, Lucas Felipe, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_su2o422fm39r6f8r6vgqghlr01